These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 34214678)
1. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Kim D; Konyn P; Cholankeril G; Ahmed A Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1438-e1455. PubMed ID: 34214678 [TBL] [Abstract][Full Text] [Related]
2. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Kim D; Vazquez-Montesino LM; Li AA; Cholankeril G; Ahmed A Hepatology; 2020 Nov; 72(5):1556-1568. PubMed ID: 32012316 [TBL] [Abstract][Full Text] [Related]
3. Physical activity and diet quality in relation to non-alcoholic fatty liver disease: A cross-sectional study in a representative sample of U.S. adults using NHANES 2017-2018. Heredia NI; Zhang X; Balakrishnan M; Daniel CR; Hwang JP; McNeill LH; Thrift AP Prev Med; 2022 Jan; 154():106903. PubMed ID: 34861339 [TBL] [Abstract][Full Text] [Related]
4. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database. Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P BMC Gastroenterol; 2022 Jul; 22(1):366. PubMed ID: 35907827 [TBL] [Abstract][Full Text] [Related]
5. Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan. Wijarnpreecha K; Aby ES; Ahmed A; Kim D J Gastrointestin Liver Dis; 2021 Jun; 30(2):227-232. PubMed ID: 33951121 [TBL] [Abstract][Full Text] [Related]
6. Association between different obesity patterns and the risk of NAFLD detected by transient elastography: a cross-sectional study. Sun J; Yan C; Wen J; Wang F; Wu H; Xu F BMC Gastroenterol; 2024 Jul; 24(1):221. PubMed ID: 38987694 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018. Zhang X; Heredia NI; Balakrishnan M; Thrift AP PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733 [TBL] [Abstract][Full Text] [Related]
8. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis. Harring M; Golabi P; Paik JM; Shah D; Racila A; Cable R; Srishord M; Younossi ZM Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2876-2888.e5. PubMed ID: 36848980 [TBL] [Abstract][Full Text] [Related]
9. Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S. Heredia NI; Zhang X; Balakrishnan M; Hwang JP; Thrift AP Ethn Health; 2023 Feb; 28(2):299-312. PubMed ID: 35067116 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data. Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177 [TBL] [Abstract][Full Text] [Related]
11. Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018. Ji Y; Wei CB; Gu W; Hou LL Ann Med; 2023 Dec; 55(1):2209335. PubMed ID: 37155562 [TBL] [Abstract][Full Text] [Related]
12. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes. Xie Y; Kong W; Wang X; Wu Z BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348 [TBL] [Abstract][Full Text] [Related]
13. Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV. Kardashian A; Lloyd A; Vilar-Gomez E; Naggie S; Sulkowski MS; Woreta T; Lake JE; Crandall H; Loomba R; Wilson LA; Sterling RK; Heath S; Gawrieh S; Chalasani NP; Price JC; Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1427-1435.e6. PubMed ID: 38582290 [TBL] [Abstract][Full Text] [Related]
14. Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States. Unalp-Arida A; Ruhl CE Dig Dis Sci; 2023 Apr; 68(4):1237-1252. PubMed ID: 36173583 [TBL] [Abstract][Full Text] [Related]
15. Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population. Ciardullo S; Monti T; Grassi G; Mancia G; Perseghin G J Hypertens; 2021 Aug; 39(8):1621-1627. PubMed ID: 33657584 [TBL] [Abstract][Full Text] [Related]
16. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434 [TBL] [Abstract][Full Text] [Related]
17. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population. Ciardullo S; Muraca E; Zerbini F; Manzoni G; Perseghin G J Clin Endocrinol Metab; 2021 Jul; 106(8):e2856-e2865. PubMed ID: 33878156 [TBL] [Abstract][Full Text] [Related]
18. Association between handgrip strength, nonalcoholic fatty liver disease, advanced hepatic fibrosis and its modifiers: Evidence from the NHANES database of the USA. Zhao X; Shi X; Gu H; Zhou W; Zhang Q J Gastroenterol Hepatol; 2023 Oct; 38(10):1734-1742. PubMed ID: 36805682 [TBL] [Abstract][Full Text] [Related]
19. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. Zhao Y; Li H Scand J Gastroenterol; 2022 Jul; 57(7):872-877. PubMed ID: 35189786 [TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population. Ciardullo S; Cannistraci R; Mazzetti S; Mortara A; Perseghin G Front Endocrinol (Lausanne); 2021; 12():711484. PubMed ID: 34381424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]